Notice on the Supervision of E-cigarette Product Quality Inspection

Sep.30.2024
Notice on the Supervision of E-cigarette Product Quality Inspection
Shenzhen Tobacco Monopoly Bureau issues notice on quality check plan for e-cigarette products sold in Shenzhen in the second half of 2024.

The Shenzhen Tobacco Monopoly Bureau has issued a notice regarding the release of the quality supervision and spot check plan for e-cigarette products sold in Shenzhen in the second half of 2024.

Notice on the Supervision of E-cigarette Product Quality Inspection


According to the relevant provisions of the "Implementation Rules for Quality Supervision Spot Checks of e-cigarette Products" (National Tobacco Bureau [2022] No. 59), the Shenzhen Tobacco Monopoly Bureau has organized the formulation of the "Supervision and Spot Check Program for the Quality of e-cigarette Products Sold in Shenzhen in the Second Half of 2024," which is now being announced.

Notice on the Supervision of E-cigarette Product Quality Inspection


The Shenzhen Tobacco Monopoly Bureau

Notice on the Supervision of E-cigarette Product Quality Inspection


September 29, 2024


The plan for quality supervision spot checks on e-cigarette products sold in Shenzhen in the second half of 2024.


Sampling method


By randomly sampling, 75 smoking accessories and compatible pods (or combination products) of each type are selected, as well as at least 80 grams of aerosolized material, divided into test samples and backup samples as required. Test samples are sent to the relevant testing institution, while backup samples are temporarily stored at the institution responsible for sampling and used as needed for spot checks. The sampling form can be found in Appendix 1.


2. Examination criteria


Judgment Rules


Based on standards.


GB 41700 refers to an e-cigarette product.


3.2 Judgment principle


After conducting tests, it was found that all tested items met the standard requirements, determining the randomly sampled products to be compliant. If any item in the test does not meet the standard requirements, the randomly sampled product is considered non-compliant.


4. Conclusion


This scheme is applicable for quality supervision spot checks on e-cigarette products sold within Shenzhen city in the second half of 2024.


Appendix 1: Sample List of E-cigarette Products


Appendix 2: Method for detecting additives in e-cigarette aerosols.


Appendix 1


E-cigarette product sampling form (applicable to individual or combined sales of smoking products, pods)


Reference Number:


Sampling Unit (Official Seal): Sampled Unit (Official Seal):


Sample person: Investigator


E-cigarette Product Sampling Form (for disposable e-cigarette products)


Serial number:


Sampling unit (official stamp): Sampled unit (official stamp):


Sample person: Handler:


Appendix 2


Method for detecting additives in e-cigarette aerosols


E-cigarette aerosol additives determination of ester compounds and D-limonene by gas chromatography-mass spectrometry (Q/CTQTC122-2021).


E-cigarette aerosol additives determination of alcohol compounds by gas chromatography" (Q/CTQTC124-2021).


E-cigarette aerosol additive determination of catechins and epicatechins by spectrophotometry and high-performance liquid chromatography" (Q/CTQTC125-2021), this spot check only measures catechins.


E-cigarette vapor additives Determination of heterocyclic compounds Gas chromatography-mass spectrometry coupling method (Q/CTQTC121-2021).


E-cigarette aerosol additive determination of ketones by gas chromatography-mass spectrometry" (Q/CTQTC123-2021).


The determination of e-cigarette aerosol additives such as eugenol, maltol, ethyl maltol, vanillin, and ethyl vanillin by high-performance liquid chromatography (Q/CTQTC126-2021).


Title: Determination of Volatile Fatty Acids (Acetic Acid, Propionic Acid, Butyric Acid, and 2-Methylbutyric Acid) in E-Cigarette Aerosol Additives by Gas Chromatography-Mass Spectrometry Coupled Method (Q/CTQTC127-2021)


Analysis of Non-volatile Organic Acids in E-liquid Additives for E-cigarettes by Liquid Chromatography-Tandem Mass Spectrometry (Q/CTQTC128-2021)


Since the submission deadline for Pre-Market Tobacco Product Applications (PMTA) in September 2020, the agency has only authorized three types of electronic cigarette devices.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Exclusive Analysis | Smoore H1 Revenue Rises 19.9% Amid Growth Concentration, Profit Pressure and Slowing Momentum
Exclusive Analysis | Smoore H1 Revenue Rises 19.9% Amid Growth Concentration, Profit Pressure and Slowing Momentum
Smoore’s first-half 2026 revenue rose 19.9%, but the results revealed growing structural risks beneath the headline growth. Heat-not-burn contributed about 61% of incremental revenue and remains driven largely by one core customer, while traditional vaping markets diverged, own-brand growth slowed and China enterprise revenue declined further. Gross profit and adjusted profit lagged revenue growth, while second-quarter revenue growth slowed to about 1.9%, putting greater focus on the quality, concentration and sustainability of Smoore’s expansion.
Capital Markets
Aug.20
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
Ahead of the Formula 1 race in Madrid, 67 Spanish and international public-health, medical and consumer organizations have sent an open letter to F1 President and CEO Stefano Domenicali calling for an end to sponsorships linked to the tobacco and nicotine industry, including nicotine pouches, vaping products and heated tobacco. The letter focuses on Philip Morris International’s ZYN partnership with Ferrari and British American Tobacco’s long-running partnership with McLaren and exposure for VELO. The campaign follows a March letter in which more than 160 organizations worldwide made a similar request to Formula 1.
Sep.10
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
IQOS opened its first global flagship, IQOS Flagship Ginza, in Tokyo on September 4, 2026, replacing the former IQOS Store Ginza after nearly a decade of operation. The new location expands conventional product retail into member lounges, digital experiences, art installations and brand programming. IQOS also launched a Ginza-exclusive IQOS ILUMA i PRIME set limited to 1,814 individually numbered units, priced at JPY11,980, or about US$77. PMI Sales Strategy Consultant Yuji M. later said on LinkedIn that more than 500 people had lined up from the night before the opening.
Sep.07
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds American, a BAT subsidiary, showcased four Vuse Pro flavored e-cigarette pods and its VELO nicotine pouch portfolio at NACS Show 2026. Booth staff confirmed to 2Firsts that the Vuse Pro flavors are sold in the U.S., although they have not received FDA marketing authorization. BAT outlined plans to expand Vuse retail distribution and reported that VELO held a 30.5% year-to-date volume share of the U.S. modern oral nicotine category through August 2026. The booth also featured the newly launched VELO MAX range and merchandising displays combining cigarettes, vaping products and oral nicotine brands.
EXPO
Oct.09
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada's federal government is considering changes to current restrictions on where nicotine pouches can be sold, potentially allowing authorized products to return to convenience stores and other general retail channels, although no decision has been made. Since 2024, emerging nicotine replacement therapy products such as nicotine pouches have been largely restricted to behind-the-counter pharmacy sales. Health Canada, meanwhile, continues to recall unauthorized and higher-strength nicotine pouches, indicating that the current discussion concerns retail access for authorized products rather than a broad relaxation of nicotine pouch regulation.
Sep.14